1. Home
  2. VIR vs IBCP Comparison

VIR vs IBCP Comparison

Compare VIR & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • IBCP
  • Stock Information
  • Founded
  • VIR 2016
  • IBCP 1864
  • Country
  • VIR United States
  • IBCP United States
  • Employees
  • VIR N/A
  • IBCP N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • IBCP Major Banks
  • Sector
  • VIR Health Care
  • IBCP Finance
  • Exchange
  • VIR Nasdaq
  • IBCP Nasdaq
  • Market Cap
  • VIR 706.4M
  • IBCP 682.2M
  • IPO Year
  • VIR 2019
  • IBCP N/A
  • Fundamental
  • Price
  • VIR $4.80
  • IBCP $31.19
  • Analyst Decision
  • VIR Strong Buy
  • IBCP Hold
  • Analyst Count
  • VIR 11
  • IBCP 3
  • Target Price
  • VIR $25.73
  • IBCP $36.00
  • AVG Volume (30 Days)
  • VIR 1.5M
  • IBCP 82.8K
  • Earning Date
  • VIR 10-30-2025
  • IBCP 10-23-2025
  • Dividend Yield
  • VIR N/A
  • IBCP 3.31%
  • EPS Growth
  • VIR N/A
  • IBCP N/A
  • EPS
  • VIR N/A
  • IBCP 3.06
  • Revenue
  • VIR $19,000,000.00
  • IBCP $217,457,000.00
  • Revenue This Year
  • VIR N/A
  • IBCP N/A
  • Revenue Next Year
  • VIR $11.08
  • IBCP $5.56
  • P/E Ratio
  • VIR N/A
  • IBCP $10.27
  • Revenue Growth
  • VIR N/A
  • IBCP 2.56
  • 52 Week Low
  • VIR $4.16
  • IBCP $26.75
  • 52 Week High
  • VIR $14.45
  • IBCP $40.32
  • Technical
  • Relative Strength Index (RSI)
  • VIR 46.19
  • IBCP 39.46
  • Support Level
  • VIR $4.75
  • IBCP $31.01
  • Resistance Level
  • VIR $5.39
  • IBCP $32.39
  • Average True Range (ATR)
  • VIR 0.30
  • IBCP 0.68
  • MACD
  • VIR -0.02
  • IBCP -0.19
  • Stochastic Oscillator
  • VIR 5.63
  • IBCP 9.30

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: